LRRK2 and Parkinson disease: Induced pluripotent stem cell-derived neural cells from patients with PD with LRRK2 mutations exhibited higher levels of mitochondrial (mtDNA) damage than cells from healthy patients without mutation; the increased mtDNA damage caused by LRRK2 mutations was reversed by genome editing [77].